About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multimodal MRI-guided rTMS to Treat Refractory Hallucinations

Multimodal MRI-guided rTMS to Treat Refractory Hallucinations

NCT01373866·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital, Lille

Age

13–60

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Right-handed Female/Male, \[13-60 y.o.\],
Schizophrenia (DSM-IV-TR diagnosis),
Drug-resistant hallucinations (Kinon \& Kane criteria, 1993),
Unmodified antipsychotic dosage during the 30 days preceding rMTS,
No anticonvulsive medication,
No neurological disorder, no addictive behavior,
Matched for sex, age and PANSS scores,
Consent to participate to the study,

You may not be if

Pregnancy
Contraindication to MRI scan
Contraindication to rTMS treatment
Claustrophobia
No social insurance

The record

StatusCompleted

PhaseNo phase

Taking part85

StartedNov 2010

UpdatedDec 26, 2025

Conditions

Hallucinations Schizophrenia Perceptual Disorders

Where2

Lille University Hospital Centre
Lille, France
Saint-Anne Psychiatric Hospital
Paris, France